The Higher Hospital Costs of Revision Total Hip Arthroplasty by Diagnosis: Analysis of Cost Drivers and Periprosthetic Joint Infection Treatment Pathways
ANZ Journal of Surgery · 2026-03 · 96 (3) · 449-457
DOI: 10.1111/ans.70368 ↗At a glance
Journal article in ANZ Journal of Surgery, published online on 2025-11-06. Written by Aaron S Hammat and 7 co-authors. Institution: Centre for Orthopaedic and Trauma Research, The University of Adelaide, Adelaide, Australia. Major MEDLINE topics: Arthroplasty, Replacement, Hip, Prosthesis-Related Infections, Reoperation, Hospital Costs. Cited 3 times so far (Crossref); 19 references.
Abstract (original language)
Background
Total hip arthroplasty (THA) is recognised to improve patients' quality of life; however revision surgery incurs a substantial burden upon patients, clinicians, hospitals and healthcare systems. This study aimed to investigate (1) the hospital costs of revision THA (rTHA) relative to primary THA (pTHA) by diagnosis and the cost drivers within each episode of care (EoC); and (2) the cumulative costs of rTHA for prosthetic joint infections (PJI) by treatment pathway.
Methods
Median hospital costs of patients undergoing pTHA ( n = 1101) or rTHA ( n = 396) at a tertiary referral hospital between 2014 and 2022 were calculated by diagnosis, cost drivers and treatment pathways. Admission and procedural data were verified across multiple hospital databases, including a prospective hospital‐based arthroplasty register. Costs were adjusted for inflation to 2024 Australian Dollars (AU$).
Results
Median cost of rTHA per EoC ($45 165) was significantly more costly than pTHA ($25 615, p < 0.05). Median rTHA cost by diagnosis increased from dislocation ($37 072), loosening ($47 708), periprosthetic fractures ($52 521) to PJI ($65 325). Within each diagnosis of rTHA, the most expensive cost drivers were ward‐related and surgical theatre costs. Regarding PJI treatment pathways, median cost was $123 688 for two‐stage rTHA, $63 261 for single stage rTHA and $51 760 for debridement and implant retention.
Conclusion
Median costs of rTHA for dislocation, loosening, periprosthetic fracture and PJI were associated with a 1.5, 1.9, 2.1 and 2.6‐fold higher cost relative to pTHA per EoC, respectively. Ongoing surgical treatment and readmission for PJI lead to complex treatment pathways and increased costs.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Centre for Orthopaedic and Trauma Research, The University of Adelaide, Adelaide, Australia.
- Department of Infectious Diseases, Royal Adelaide Hospital, Adelaide, Australia.
- Faculty of Health and Medical Science, The University of Adelaide, Adelaide, Australia.
- Wakefield Orthopaedic Clinic, Calvary Adelaide Hospital, Adelaide, Australia.
- Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Adelaide, Australia.
- Adelaide EpiCentre, The University of Adelaide, Adelaide, Australia.
ORCID profiles: Aaron S Hammat, Taisha D'Apollonio, Renjy Nelson, David Campbell, Boopalan Ramasamy, L Bogdan Solomon, Emmanuel S Gnanamanickam, Stuart A Callary
Cite
APA
Hammat, A. S., D'Apollonio, T., Nelson, R., Campbell, D., Ramasamy, B., Solomon, L. B., Gnanamanickam, E. S., & Callary, S. A. (2026). The Higher Hospital Costs of Revision Total Hip Arthroplasty by Diagnosis: Analysis of Cost Drivers and Periprosthetic Joint Infection Treatment Pathways. ANZ Journal of Surgery, 96(3), 449-457. https://doi.org/10.1111/ans.70368
Vancouver
Hammat AS, D'Apollonio T, Nelson R, Campbell D, Ramasamy B, Solomon LB, et al. The Higher Hospital Costs of Revision Total Hip Arthroplasty by Diagnosis: Analysis of Cost Drivers and Periprosthetic Joint Infection Treatment Pathways. ANZ Journal of Surgery. 2026;96(3):449-457. doi:10.1111/ans.70368
BibTeX
@article{Hammat2026,
author = {Hammat, Aaron S and D'Apollonio, Taisha and Nelson, Renjy and Campbell, David and Ramasamy, Boopalan and Solomon, L Bogdan and Gnanamanickam, Emmanuel S and Callary, Stuart A},
title = {The Higher Hospital Costs of Revision Total Hip Arthroplasty by Diagnosis: Analysis of Cost Drivers and Periprosthetic Joint Infection Treatment Pathways},
journal = {ANZ Journal of Surgery},
year = {2026},
volume = {96},
number = {3},
pages = {449--457},
doi = {10.1111/ans.70368}
}
EUVIMED